Serious Infections in Two Large US and Swedish Rituximab-treated Multiple Sclerosis Cohorts

被引：0
|
作者：
Langer-Gould, Annette [1 ]
Smith, Jessica [1 ]
Piehl, Fredrik [2 ]
Li, Bonnie [1 ]
Frisell, Thomas [2 ]
机构：
[1] Kaiser Permanente Southern Calif, Pasadena, CA USA
[2] Karolinska Inst, Stockholm, Sweden
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S26.007
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Aging with multiple sclerosis: A longitudinal study of physical function, mental health, and memory in two cohorts of US women
    Cortese, Marianna
    Bjornevik, Kjetil
    Chitnis, Tanuja
    Ascherio, Alberto
    Munger, Kassandra L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (01) : 121 - 131
  • [42] FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
    Danilova, Olga V.
    Dumont, Larry J.
    Levy, Norman B.
    Lansigan, Frederick
    Kinlaw, William B.
    Danilov, Alexey V.
    Kaur, Prabhjot
    JOURNAL OF HEMATOPATHOLOGY, 2013, 6 (01) : 11 - 18
  • [43] FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
    Olga V. Danilova
    Larry J. Dumont
    Norman B. Levy
    Frederick Lansigan
    William B. Kinlaw
    Alexey V. Danilov
    Prabhjot Kaur
    Journal of Hematopathology, 2013, 6 : 11 - 18
  • [44] Uncommon infections in multiple sclerosis patients treated with natalizumab
    Fritz-Fiaux, A.
    Goebels, N.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S124 - S124
  • [45] Phenotype of repleting B cells in multiple sclerosis patients treated with rituximab
    Nissimov, N.
    Hajiyeva, Z.
    Brueck, W.
    Haeusser-Kinzel, S.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 767 - 767
  • [46] Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab
    Kintrilis, Nikos
    Gkinos, Charilaos P.
    Galinos, Iosif
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [47] Outcome of secondary progressive multiple sclerosis patients treated with rituximab or alemtuzumab
    Aguirre, C.
    Meca-Lallana, V.
    Sanchez, P.
    del Rio, B.
    Garcia-Vaz, F.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 157 - 157
  • [48] Reduction in JCV antibody titers in multiple sclerosis patients treated with rituximab
    Siddiqui, Ursela
    Sloane, Jacob
    Egnor, Emily
    Johnson, Pamela
    Mojica, Chamariela
    NEUROLOGY, 2017, 88
  • [49] COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
    Iyer, Rajesh B.
    Raghavendra, S.
    Nooraine, Javeria M.
    Jaychandran, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [50] Incidence of Infections and Prophylaxis Practice, in Two Cohorts of Patients of Autoimmune Disorders of Hematological Interest or Non-Hodgkin Lymphoma Treated with Rituximab
    Perrone, Salvatore
    Tomasello, Riccardo
    Raso, Simona
    Annibali, Ombretta
    Tafuri, Mariantonietta
    Mattana, Marta
    Soriano, Tania
    Fanciullo, David
    Assanto, Giovanni Manfredi
    Pedone, Giacinto Luca
    Baldacci, Erminia
    Santacroce, Eugenio
    Ingrasci, Manuela Giuseppa
    Biglietto, Mario
    Cammarata, Claudia
    Totaro, Matteo
    Ligia, Silvio
    Fattizzo, Bruno
    Santoro, Cristina
    Siragusa, Sergio
    Napolitano, Mariasanta
    BLOOD, 2024, 144 : 5395 - 5396
12345